Get started
Author

Adrien Buisson

Observed name: Buisson, Adrien
ORCID: 0000-0002-8924-7776
Observed ORCID: 0000-0002-8924-7776
OpenAlex ID: A5104255478
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
2020 · Solene De Talhouet, Julien Peron, et al. · Scientific Reports · 134
PDF
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025 · Caroline Abadie, Aldja Abderrahmane, et al. · The Lancet Regional Health - Europe · 69
PDF
Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis
2019 · Alain Calender, Clarice X. Lim, et al. · European Respiratory Journal · 59
PDF
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer
2017 · S. Intidhar Labidi-Galy, Timothée Olivier, et al. · Clinical Cancer Research · 59
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis
2018 · in the frame of GSF (Groupe Sarcoïdose France), Alain Calender, et al. · BMC Medical Genomics · 38
PDF
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
2021 · Sandrine M. Caputo, Lisa Golmard, et al. · The American Journal of Human Genetics · 37
PDF
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer
2021 · Romain Cohen, Vincent Jonchère, et al. · Journal for ImmunoTherapy of Cancer · 32
PDF
Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics
2022 · Arnaud de la Fouchardiere, Franck Tirode, et al. · The American Journal of Surgical Pathology · 30
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers
2019 · S. Intidhar Labidi-Galy, Thibault de La Motte Rouge, et al. · Gynecologic Oncology · 29
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
2019 · Alex Friedlaender, Aurélie Vuilleumier, et al. · Breast Cancer Research and Treatment · 24
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles
2023 · Christian Pozzorini, Gregoire Andre, et al. · Cell Reports Medicine · 23
PDF
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
2022 · Elise Bonnet, Véronique Haddad, et al. · Journal of Personalized Medicine · 13
PDF
The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23—a likely pathogenic variant with reduced penetrance?
2020 · Hildegunn Høberg-Vetti, Elisabet Ognedal, et al. · European Journal of Human Genetics · 13
PDF
Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort
2023 · Ahmed Bouras, Souhir Guidara, et al. · Cancers · 11
PDF
Compound blue nevus: a reappraisal of the concept in the genomic era
2019 · Julien Jaquemus, Emilie Perron, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 10
A deep learning solution for detection of homologous recombination deficiency in ovarian cancer using low pass whole-genome sequencing: Evaluation of the analytical performance.
2022 · Adrien Buisson, Pierre Saintigny, et al. · Journal of Clinical Oncology · 8
Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report
2021 · Orion Valet, Aurélie Swalduz, et al. · JTO Clinical and Research Reports · 8
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
2020 · Solene De Talhouet, Julien Peron, et al. · Scientific Reports · 8
PDF
Supravalvular Aortic Stenosis Caused by a Familial Chromosome 7 Inversion Disrupting the ELN Gene Uncovered by Whole-Genome Sequencing
2019 · Linda Pons, Patrice Bouvagnet, et al. · Molecular Syndromology · 8
PDF
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2− Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial
2025 · Séverine Guiu, Judith Balmaña, et al. · Clinical Cancer Research · 5
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories
2025 · Edwige Kasper, Flavie Boulouard, et al. · International Journal of Cancer · 5
PDF
Blinded-assessment of a solution to evaluate olaparib maintenance treatment efficacy in patients with ovarian cancer from the GINECO/ENGOT PAOLA-1 trial.
2023 · Adrien Buisson, Pierre Saintigny, et al. · Journal of Clinical Oncology · 5
PDF
2022-RA-913-ESGO Clinical performance evaluation of a novel deep learning solution for homologous recombination deficiency detection
2022 · Adrien Buisson, Pierre Saintigny, et al. · International Journal of Gynecological Cancer · 5
PDF
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
2021 · Romain Varnier, Thibaut Garrivier, et al. · Frontiers in Oncology · 5
PDF
Gynecological carcinosarcomas: Overview and future perspectives
2023 · Laetitia Collet, Andrea María González López, et al. · Bulletin du Cancer · 4
PDF
Works count: 60
Citation count: 651
H-index: 13
I10-index: 15
Year
Topic
Type